IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,431,878 | -17.4% | 1,098,417 | -1.7% | 0.11% | -12.9% |
| Q2 2023 | $21,096,075 | +351.4% | 1,117,969 | -8.1% | 0.12% | +313.3% |
| Q1 2023 | $4,673,825 | -12.0% | 1,217,142 | +13.6% | 0.03% | -14.3% |
| Q4 2022 | $5,313,901 | +2.8% | 1,071,351 | -0.9% | 0.04% | -2.8% |
| Q3 2022 | $5,167,000 | -1.1% | 1,081,008 | -6.9% | 0.04% | +5.9% |
| Q2 2022 | $5,225,000 | -6.5% | 1,161,213 | -1.1% | 0.03% | +13.3% |
| Q1 2022 | $5,588,000 | -33.6% | 1,173,855 | +3.5% | 0.03% | -33.3% |
| Q4 2021 | $8,418,000 | +29.4% | 1,134,470 | -1.1% | 0.04% | +28.6% |
| Q3 2021 | $6,505,000 | -12.3% | 1,147,194 | +1.9% | 0.04% | -12.5% |
| Q2 2021 | $7,421,000 | -24.5% | 1,126,085 | -7.2% | 0.04% | -27.3% |
| Q1 2021 | $9,825,000 | +16.0% | 1,212,909 | -7.6% | 0.06% | +10.0% |
| Q4 2020 | $8,469,000 | +102.7% | 1,313,077 | +13.1% | 0.05% | +92.3% |
| Q3 2020 | $4,178,000 | -50.3% | 1,160,512 | -36.5% | 0.03% | -51.9% |
| Q2 2020 | $8,412,000 | +54.2% | 1,828,760 | +14.3% | 0.05% | +38.5% |
| Q1 2020 | $5,456,000 | -49.2% | 1,600,078 | -24.0% | 0.04% | -20.4% |
| Q4 2019 | $10,742,000 | +142.3% | 2,104,217 | +14.9% | 0.05% | +145.0% |
| Q3 2019 | $4,434,000 | +40.1% | 1,832,085 | +25.6% | 0.02% | +42.9% |
| Q2 2019 | $3,166,000 | -15.2% | 1,459,127 | +5.9% | 0.01% | -17.6% |
| Q1 2019 | $3,733,000 | -29.4% | 1,377,413 | +25.1% | 0.02% | -32.0% |
| Q4 2018 | $5,285,000 | -40.4% | 1,101,037 | +17.5% | 0.02% | -24.2% |
| Q3 2018 | $8,871,000 | +0.9% | 936,788 | +3.7% | 0.03% | -5.7% |
| Q2 2018 | $8,789,000 | -2.1% | 903,307 | +5.8% | 0.04% | 0.0% |
| Q1 2018 | $8,981,000 | +96.2% | 853,700 | +19.6% | 0.04% | +105.9% |
| Q4 2017 | $4,577,000 | -34.9% | 714,067 | -22.3% | 0.02% | -39.3% |
| Q3 2017 | $7,034,000 | -36.3% | 919,509 | -40.8% | 0.03% | -36.4% |
| Q2 2017 | $11,043,000 | +93.9% | 1,553,138 | +5.5% | 0.04% | +83.3% |
| Q1 2017 | $5,696,000 | +105.5% | 1,471,763 | +8.3% | 0.02% | +84.6% |
| Q4 2016 | $2,772,000 | +23.0% | 1,358,863 | +61.6% | 0.01% | +18.2% |
| Q3 2016 | $2,253,000 | +206.9% | 840,804 | +253.0% | 0.01% | +175.0% |
| Q2 2016 | $734,000 | +784.3% | 238,155 | +2344.6% | 0.00% | – |
| Q1 2016 | $83,000 | – | 9,742 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |